Next Level Ventures

Next Level Ventures is a strategic investment firm based in Des Moines, Iowa, specializing in supporting companies that aim to scale rapidly from seed to growth stages. With over 20 years of experience, the firm has managed multiple funds and invested in more than 150 primary investments and 75 portfolio-led acquisitions. Their focus spans various sectors, including agriculture, banking, insurance, biosciences, advanced manufacturing, and information technology. The firm typically invests between $0.5 million and $5 million for a minority ownership stake in companies with annual sales of at least $1 million. Beyond capital, Next Level Ventures offers management expertise and actively engages with portfolio companies, often serving on their boards. As a certified Iowa Innovation Fund, they play a significant role in contributing to the region's economic development.

In January 2025, Next Level Ventures launched its third Iowa-focused investment fund, Next Level Ventures Fund III, raising over $15 million and completing its first investment in Ames-based Genvax Technologies, a company developing mRNA and nanoparticle animal vaccines. This fund remains open to accredited investors. The firm's previous funds include Curql Fund II, which closed in August 2025, and other earlier funds that have supported various startups across the Midwest.

Next Level Ventures is also actively involved in the Iowa venture capital community, with representatives serving on the board of the Iowa Venture Capital Association (IVCA). The firm's commitment to fostering innovation and economic growth in Iowa is evident through its investments and collaborative efforts with local entrepreneurs and industry leaders.